Health economic assessment of Luxturna in the treatment of visual impairment caused by hereditary eye disease

29 May 2019 - TLV has produced a health economic knowledge base for the region for the drug Luxturna (voretigene ...

Read more →

Health economic assessment of Tegsedi in hereditary transthyretin amyloidosis

17 May 2019 - TLV has produced a health economic knowledge base for the regions for Tegsedi (inotersen) that treat hereditary ...

Read more →